Who are GnRH agonist trigger's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lupron, Micronor, Half-Dose Depot Triptorelin, Lupron Depot, Gonapeptyl®, triptorelin 0.1.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gnrh-agonist-trigger.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

GnRH agonist trigger — Competitive Intelligence Brief

GnRH agonist trigger (GnRH agonist trigger) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GnRH agonist. Area: Reproductive Medicine / Fertility.

marketed GnRH agonist GnRH receptor Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

GnRH agonist trigger (GnRH agonist trigger) — Rambam Health Care Campus. GnRH agonist trigger induces a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to trigger final oocyte maturation and ovulation in assisted reproductive technology cycles.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
GnRH agonist trigger TARGET	GnRH agonist trigger	Rambam Health Care Campus	marketed	GnRH agonist	GnRH receptor
Lupron	leuprorelin	Accord Healthcare S.L.U.	marketed	Gonadotropin Releasing Hormone Receptor Agonist	GnRH receptors	1985-01-01
Micronor	norethisterone	Johnson & Johnson	marketed	Progestin	GnRH receptors	1962-01-01
Half-Dose Depot Triptorelin	Half-Dose Depot Triptorelin	Tehran University of Medical Sciences	marketed	GnRH agonist	GnRH receptor
Lupron Depot	Lupron Depot	University of Michigan Rogel Cancer Center	marketed	GnRH agonist	GnRH receptor
Gonapeptyl®	Gonapeptyl®	University Hospital, Ghent	marketed	GnRH agonist	GnRH receptor
triptorelin 0.1	triptorelin 0.1	Chong Qing Reproducive and Genetic Institute	marketed	GnRH agonist	GnRH receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-03-22 — Lupron · 9617303 · US
2031-02-05 — Lupron · 8921326 · US

Sponsor landscape (GnRH agonist class)

Takeda · 4 drugs in this class
Abbott · 3 drugs in this class
Ipsen · 3 drugs in this class
Changchun GeneScience Pharmaceutical Co., Ltd. · 3 drugs in this class
University of Pisa · 2 drugs in this class
Chong Qing Reproducive and Genetic Institute · 1 drug in this class
Chesapeake Urology Research Associates · 1 drug in this class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
Enteris BioPharma Inc. · 1 drug in this class
Colorado Center for Reproductive Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GnRH agonist trigger — Competitive Intelligence Brief. https://druglandscape.com/ci/gnrh-agonist-trigger. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab